AUTHOR INDEX

A B C Ç D E F G H I İ J K L M N O Ö P R S Ş T U Ü V Y Z
TABAK

Fehmi TABAK

Evaluation of Various Aspects of HBsAg and Anti-HBs Negative, Anti-HBs Positive Cases

(Viral Hepat J 1996; 2: 92-95)

The Seroprevalence of Hepatitis A Virus in Patients with Chronic Hepatitis

(Viral Hepat J 2004; 9: 152-155)

The Long Term Follow-up Results of Chronic Hepatitis B Cases: Cerrahpasa Experience

(Viral Hepat J 2011; 17: 32-36)

Determination of Liver Disease in Incidentally Detected HBsAg Positives

(Viral Hepat J 2012; 18: 52-56)

Foreword

(Viral Hepat J 2013; 19: -)
Tabak

Fehmi Tabak

Waiting for Interferon-free Regimens for Chronic Hepatitis C Patients: A Multicenter Observational Study

(Viral Hepat J 2014; 20: 95-100)

Comparison of Chemiluminescence Microparticle Immunoassay and Electrochemiluminescence Immunoassay for Detection of HBsAg

(Viral Hepat J 2014; 20: 101-105)

Editorial

(Viral Hepat J 2014; 20: 0-0)

Hepatitis B Virus: Biology and Life Cycle

(Viral Hepat J 2015; 21: 1-7)
TABAK

Fehmi TABAK

Editorail

(Viral Hepat J 2015; 21: 0-0)

The Relationship Between the Methods of Male Circumcision Procedures Used in the Past and the Prevalence of Viral Hepatitis

(Viral Hepat J 2016; 22: 6-9)

Editorial

(Viral Hepat J 2016; 22: 0-0)

Editorial

(Viral Hepat J 2016; 22: 0-0)

Editorial

(Viral Hepat J 2016; 22: -)

Editorial

(Viral Hepat J 2017; 23: -)

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals

(Viral Hepat J 2017; 23: 6-9)
Home Archive Search Menu